Oncolytic Virus Immunotherapy Market To Register Double Digit Growth USD 4.75 Billion by 2032

global Oncolytic Virus Immunotherapy Market was worth USD 2.70 Billion in 2023. The market is forecast to reach USD 4.75 Billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2024-2032, as per Zion Market Research Report. Furthermore, oncolytic virus immunotherapy makes use of oncolytic virus for attaching to cancer tumor cells and then eliminating them. In addition to this, these viruses are produced in a way that they do not infect healthy cells in human beings and focus on targeting tumors to destroy them. This results in improving immune system of body and helps in release of cancer antigens prompting immune response which can eradicate remaining cancer cells in body. All these aspects will encourage use of oncolytic virus immunotherapy for treating cancer, thereby augmenting market growth.

Rise in Clinical Trials & Research Pertaining To Efficacy Of Oncolytic Virus For Cancer Treatment To Drive Market Growth

Expansion of oncolytic virus immunotherapy market during forecasting years can be attributed to increase in research & development activities related to effectiveness of use of oncolytic virus as drug in cancer treatment. A Large number of research papers published in reputed journals related to oncology and use of oncolytic virus as an effective mode of treating cancer is likely to enhance & accelerate popularity of oncolytic virus immunotherapy. Large number of pharma and healthcare firms are studying oncolytic virus for its use in treating breast cancer, glioblastoma, and melanoma, thereby driving growth of oncolytic virus immunotherapy market. Furthermore, increase in ongoing healthcare research activities to increase lifespan of individuals along with need for eliminating chronic ailments such as cancer will boost market trends.

North American Oncolytic Virus Immunotherapy Market To Dominate Regional Landscape By 2032

The growth of oncolytic virus immunotherapy market in North America during assessment period can be ascribed to large number of melanoma cancer patients found in countries such as the U.S. Apart from this, a prominent rise in cases of breast cancer in sub-continent has further added to demand for oncolytic virus immunotherapy. Moreover, increase in sponsorship rate and presence of leading pharma & biotech firms in Canada and the U.S. will contribute significantly towards regional market volume as well as market value in forthcoming years.  Huge growth prospects of industry in region can also be attributed to proactiveness demonstrated by regional government in promoting new therapies & clinical research for treating cancer will prompt regional market growth.

Key participants profiled in study and leveraging market growth are Shanghai Sunway Biotech, Lokon Pharma AB, Oncolytics Biotech, Inc., Amgen, Inc., VCN Biosciences, Genelux Corporation, Transgene sa, Cold Genesys, Inc., Takara Bio, DNAtrix Therapeutics, Viralytics Ltd., Turnstone Biologics, and Vyriad.  

Browse the full “Oncolytic Virus Immunotherapy Market - By Application (Melanoma, Myeloma, Bladder Cancer, Ovarian Cancer, Prostrate Cancer, Lung Cancer, And Breast Cancer), By Product Type (HSV-Based Oncolytic Viruses, Vaccinia Virus-Based Oncolytic Viruses, Adenovirus-Based Oncolytic Viruses, Newcastle Disease Virus-Based Oncolytic Viruses, And Vesicular Stomatitis Virus-Based Oncolytic Viruses), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2024-2032.” Report at https://www.zionmarketresearch.com/report/oncolytic-virus-immunotherapy-market

The global Oncolytic Virus Immunotherapy Market is segmented as follows:

By Application

• Melanoma
• Bladder Cancer
• Ovarian Cancer
• Prostrate Cancer
• Lung Cancer
• Breast Cancer
• Myeloma

By Product Type

• HSV-based Oncolytic Viruses
• Vaccinia Virus-based Oncolytic Viruses
• Adenovirus-based Oncolytic Viruses
• Newcastle Disease Virus-based Oncolytic Viruses
• Vesicular Stomatitis Virus-based Oncolytic Viruses

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com